Biological evaluation of 7-O-amide hesperetin derivatives as multitarget-directed ligands for the treatment of Alzheimer's disease
Authors:
- 1 January 2021
- journal article
- research article
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 334, 109350
Abstract
No abstract availableKeywords
Funding Information
- Anhui Department of Education
This publication has 29 references indexed in Scilit:
- Novel Therapeutic Strategies for DementiaCNS & Neurological Disorders - Drug Targets, 2016
- Novel Tacrine–Benzofuran Hybrids as Potent Multitarget-Directed Ligands for the Treatment of Alzheimer’s Disease: Design, Synthesis, Biological Evaluation, and X-ray CrystallographyJournal of Medicinal Chemistry, 2015
- P7C3 Attenuates the Scopolamine-Induced Memory Impairments in C57BL/6J MiceNeurochemical Research, 2015
- Alzheimer’s Disease: A Report From the 7th Kuopio Alzheimer SymposiumNeurodegenerative Disease Management, 2015
- Amyloid-Beta: A Crucial Factor in Alzheimer's DiseaseMedical Principles and Practice, 2014
- Antioxidant and Anti-Inflammatory Properties of the Citrus Flavonoids Hesperidin and Hesperetin: An Updated Review of their Molecular Mechanisms and Experimental ModelsPhytotherapy Research, 2014
- Oxidative stress in Alzheimer’s diseaseNeuroscience Bulletin, 2014
- 2‐Phenylethynyl‐butyltellurium attenuates amyloid‐β peptide(25–35)‐induced learning and memory impairments in miceJournal of Neuroscience Research, 2013
- Molecular mechanisms of neuropathological changes in Alzheimer’s disease: a reviewFolia Neuropathologica, 2013
- Genesis and development of DPPH method of antioxidant assayJournal of Food Science and Technology, 2011